PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

The Biotech Growth Trust plc (BIOG.L) Diversifiers

Equity · Currency in GBp · Last updated Aug 1, 2026
Documentation

The Biotech Growth Trust plc is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust plc. The Biotech Growth Trust plc was formed on May 20, 1997 and is domiciled in the United Kingdom.

Looking to balance out your exposure to BIOG.L? The ETFs below have historically moved differently from BIOG.L, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.

Best Diversifiers for BIOG.L

0 ETFs have low correlation with BIOG.L (below 0.3), 0 of which are negatively correlated. The least correlated is L&G Healthcare Breakthrough UCITS ETF (DOCG.L) (Health & Biotech Equities) with a 1Y correlation of 0.50, roughly unchanged from 0.57 over 5 years.

How candidates are selected
SymbolNameCorrelation 1YCorrelation 3YCorrelation 5YRisk / Return RankCategoryCompare
DOCG.L
L&G Healthcare Breakthrough UCITS ETF0.500.510.57
63
Health & Biotech EquitiesBIOG.L vs DOCG.L

Rows per page

1–1 of 1

Diversification Analysis

Build a portfolio that complements BIOG.L

Add BIOG.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with BIOG.L